Medication misadventure in cancer care

Area of Science:

• Healthcare quality and patient safety
• Clinical pharmacology
• Oncology nursing

Background:

• Medication errors pose a substantial risk in healthcare settings.
• The complexity of cancer treatment regimens exacerbates this risk.
• Vulnerable patient populations, such as those with cancer, require specialized attention.

Purpose of the Study:

• To delineate the nature and extent of medication errors in healthcare.
• To identify implications for effective error reduction and prevention strategies.
• To highlight the specific needs of cancer patients in medication safety initiatives.

Main Methods:

• Systematic review of relevant articles and research studies.
• Analysis of existing literature on medication errors.
• Synthesis of findings related to prevention and risk reduction.

Main Results:

• Chemotherapeutic regimens and supportive care drugs increase medication error potential.
• Physiologic vulnerability in cancer patients heightens the impact of errors.
• Interdisciplinary approaches are crucial for effective prevention.

Conclusions:

• Patients with cancer should be central to interdisciplinary medication error prevention programs.
• Nurses are pivotal in enhancing patient safety and implementing interventions.
• Targeted strategies are necessary to improve the drug delivery process for cancer patients.